Category Medicine and Healthcare
Press Release
Enrollment Initiated in Jaguar Health Study of its FDA Conditionally Approved Canalevia-CA1 Prescription Drug for Dogs
Company strategy: In discussions with multiple potential animal health company partners to collaborate to bring Canalevia®, conditionally approved for CID, to regulatory approval and commercialization for general diarrhea globally Diarrhea is one of the most common reasons owners bring their dog to the veterinarian and the second most common reason for visits to the veterinary emergency hospital, yet there are currently no FDA-approved drugs to treat general diarrhea in dogs Jaguar CEO Lisa Conte presenting July 17 at Emerging Growth Conference to provide updates on near-term catalysts; Click here to register Read More
Press Release
Moderna Receives Full U.S. FDA Approval for COVID-19 Vaccine, Spikevax, in Children Aged 6 Months Through 11 Years at Increased Risk for COVID-19 Disease
Spikevax is now approved for all adults aged 65 years and older, and individuals aged 6 months through 64 years at increased risk for COVID-19 disease Read More
Press Release
The Revolutionary Resurfacing Laser Treatment That Finally Works on ALL Skin Tones (And I'm Honestly Shocked by the Results)
UltraClear laser is now available at The Naderi Center, offering safe, effective skin resurfacing for all skin tones with reduced downtime and heat-related risks. Read More
Press Release
Water Tower Research Highlights Growing Momentum for Ainos' Scent-Tech Solutions and Industrial SmellTech Leadership with New High-Impact Partnerships
Ainos Pioneers SmellTech as the Next Sensory Frontier in Industrial AI 2H 2025 Industrial Pilots and Subscription Model Poised to Unlock Multi-Million Dollar Revenue Potential in 2026 Read More
Press Release
DEA DIVERSION THE NEW PHARMACEUTICAL ROADBLOCK: Take the case of MMJ's Cannabis Drug Development
The DEA Diversion Control Problem: A Hidden Threat to U.S. Pharmaceutical Manufacturing ? Take the case of MMJ BioPharma Cultivation - despite submissions of FDA Investigational New Drug (IND) applications and Orphan Drug Designation approval for treating Huntington's Disease - has been blocked from manufacturing cannabis-derived pharmaceuticals by the DEA, under the leadership of Deputy Administrator Thomas Prevoznik. Read More
Press Release
Best Dental Health Supplements in 2025? Dentitox Pro Review Reveals a Natural Gum and Teeth Strengthening Breakthrough
New 2025 Review Highlights How Dentitox Pro's Liquid Formula Combines Vitamins, Minerals, and Plant-Based Extracts to Support Gum Health, Strengthen Teeth, and Address Root Causes of Oral Inflammation Naturally Read More
Press Release
Interactive Strength Inc. (Nasdaq: TRNR) Receives "Buy" Rating and $15 Price Target in Maxim Group Research Initiation
First comprehensive sell-side report on TRNR cites more than 800% growth in expected 2025 revenue Valuation driven by stock-for-stock M&A model and potential crypto-treasury upside Read More
Press Release
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB(TM), its New Sublingual Pre-Workout Supplement
Early positive consumer testimonials from initial Company product sampling Sublingual nano technology delivers caffeine rapidly to the bloodstream, bringing its unique benefits to the pre-workout market Developed through over a decade of scientific research to deliver a patent-pending, fast-acting supplement formulation for maximum effect Completed initial production in four flavors Aspire to launch BUZZ BOMB™ at the FITCON and Fit Expo conventions in August Read More
Press Release
AGFA HealthCare Achieves HITRUST I1 Certification, Demonstrating Its Commitment to and Compliance With Data Protection Standards, and Protecting Against Cybersecurity Threats
HITRUST certification validates that AGFA HealthCare is operating using leading security practices to protect sensitive information. Read More
Press Release
Best Eye Supplement of 2025? Visium Pro Review Reveals Herbal Vision Support Backed by Science
A science-backed review of Visium Pro's herbal formula reveals how this top-rated eye supplement helps reduce digital eye strain, improve night vision, and support long-term ocular health in 2025. Read More
Press Release
Coca Access and Benefit Sharing Agreement Authorized by Peru's National Institute of Agrarian Innovation (INIA) Supports Research Efforts of Jaguar Health and Filament Health Joint Venture, Magdalena Biosciences, into Potential Mental Health and CNS Indications of Coca
Magdalena is focused on developing novel, natural prescription medicines derived from plants for mental health indications Read More
Press Release
CBDL Announces Strategic Rollout on Vibe Performance Network, Elevating 8000MG Pain Cream to National Streaming Audiences
CBD Life Sciences Inc. (OTC:CBDL) expands its digital advertising arsenal through the Vibe Performance Network, positioning its flagship 8000MG Pain Cream in front of millions of engaged, wellness-focused viewers - unlocking massive revenue potential and long-term shareholder value in the booming CBD market. Read More
Press Release
Dermata Receives Notice of Grant of Australian Patent for Topical Botulinum Toxin Treatment for Hyperhidrosis
- This is the Company's second granted patent for DMT410, using its Spongilla technology to topically deliver botulinum toxin for hyperhidrosis - - The Company recently entered into a Clinical Trial Collaboration Agreement with Revance to study DMT410 for the treatment of axillary hyperhidrosis - Read More
Press Release
MMJ International Redefines Medical Cannabis with First Plant-Based Drug for a Rare Neurological Disease
From Plant to Pill: MMJ-001 Marks a Pharmaceutical First in Cannabis Medicine with FDA-Grade Formulation for a Devastating Neurological Disorder while awaiting final FDA approval for use in clinical trials. Read More
Press Release
Lobe Sciences Announces Validation of European Unitary Patent for DHA-Based Composition for Sickle Cell Disease
European Unitary Patent EP4117446 Validated - Lobe Sciences secures patent protection in 17 EU member states for its DHA and egg yolk-based composition designed to manage Sickle Cell Disease. Covers Altemia(R) Medical Food Formula - The patented composition underpins Altemia(R), a physician-supervised medical food formulated to address long-chain fatty acid deficiencies common in SCD patients. Supports Global Expansion Strategy - Validation strengthens Lobe's IP portfolio and enables broader commercialization of Altemia(R) across key European markets. Read More
Press Release
DEA Cannabis Poisoned, Zero Oversight-Massachusetts Lab Scandal: A Case Study in DEA's Regulatory Collapse
Poisoned Cannabis, Zero DEA Oversight The DEA's mission statement is a sham under Thomas Prevoznik's watch. Americans are being poisoned by untested state cannabis operators while terminal patients are denied potential cures. Read More
Press Release
Amomi: The Lifelong Women's Health App Expanding Its Presence in the U.S. Market
"At that time, I truly understood how hopeless and desperate it can feel for women trying to get pregnant naturally-before even considering expensive treatments like IVF," said Caroline. "I wanted to build something that actually remembers and respects women's history. That's what Amomi is." Read More
Press Release
BloodVitals Reviews Reveal Breakthrough in Painless Blood Oxygen Monitoring for Seniors
With over 2,000 verified reviews and growing demand nationwide, BloodVitals is transforming how seniors track blood oxygen and heart rate levels-completely needle-free and from the comfort of home. Read More
Press Release
UltraK9 Pro Leads the 2025 Gut Health Revolution for Dogs With Breakthrough Digestive Vitality Formula
Amid the 2025 surge in microbiome-focused pet health innovation, UltraK9 Pro emerges as a liquid, primal nutrient-based dog supplement formulated to optimize digestive wellness, support nutrient absorption, and promote full-spectrum vitality through gut-targeted delivery. Read More
Press Release
EaroPro's HD Smart Cleaner Redefines Earwax Removal With Real-Time Camera Precision in 2025 Surge
Surging demand for at-home visual ear care fuels EaroPro's rise as a doctor-endorsed solution featuring 1080p HD camera, IP67 waterproofing, and 100Hz vibration tech - projected to lead the $4.3B ear hygiene market by 2035. Read More
Press Release
Backing the Future of Preemptive Health: Glen Ventures Leads Investment in Sensifai Health
Sensifai emerges from stealth with a landmark peer-reviewed study in The Lancet Digital Health, validating its world-first AI platform to detect inflammatory events before symptoms, redefining how and when care begins. Read More
Press Release
DEA Architect of Marijuana Obstruction Matthew Strait Retires - Who Cleans Up His Marijuana Policy Mess?
The DEA's in-house administrative court system has been dealt a severe blow by recent U.S. Supreme Court rulings. Axon v. FTC (2023) and Jarkesy v. SEC (2024) have unequivocally declared this system unconstitutional, effectively rendering years of DEA imposed delays and administrative hearings illegitimate. In a significant move, the Department of Justice has formally refused to defend this unconstitutional system, potentially exposing current and former DEA leadership to civil rights litigation and heightened judicial oversight. Read More
Press Release
ReadyRx - GLP-1 Offers Structured 3, 6, and 12-Month Support Plans to Promote Balanced Weight Management Naturally
ReadyRx - GLP-1 introduces a physician-guided support framework offering structured 3-, 6-, and 12-month access to compounded GLP-1 protocols, combining clinical oversight with habit-forming wellness strategies for sustainable weight management. Read More
Press Release
Scientific Backing Grows for Metformin as Anti-Aging Pill: ReadyRx Offers Virtual Access to Evidence-Based Longevity Care
2025 Longevity Programs From ReadyRx Integrate Clinical Data, Primate Research, and TAME Trial Insights to Deliver Personalized Metformin Therapy via Secure Telehealth Platform Read More
Press Release